Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib, Fludarabine and Cyclophosphamide in Recurrent MCL
NCT01322776Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in mantle cell lymphoma (MCL), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
bortezomib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT01322776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01322776.